Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedA new site, Advanced Urology Institute 1, was added and the previous Advanced Urology Institute was removed. The page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check13 days agoChange Detected- Removed the topic 'Bladder cancer' and the related topic 'MedlinePlus Genetics' from the page's topic list.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded related topic 'Bladder cancer' and MedlinePlus Genetics link. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRecruitment status changed from Recruiting to Completed on 2026-03-13, indicating enrollment has finished.SummaryDifference0.3%

- Check50 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedRecruitment status changed from Recruiting to Completed and enrollment updated to 235, with the page revision noted as v3.4.2 on 2026-02-13.SummaryDifference0.4%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.